Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiolex in Dravet Syndrome
NCT02091375Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of cannabidiol in Dravet syndrome, sponsored by Jazz Pharmaceuticals plc. Started Mar 2015; status: completed.
02
Drugs
cannabidiol
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT02091375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091375.